TEVA Teva Pharmaceutical Industries Ltd.

9.330.03 (+0.32%)
Close: November 11, 2019

Quote

Previous Close
$9.33
Day Range
$9.21-$9.60
52 Week Range
$6.07-$23.97
Volume
22,118,333
Avg Volume
22,393,332
Dividend TTM
-
Ex-Dividend Date
2017-11-27

Valuation

Market Cap
$10.20B
Enterprise Value (EV)
$37.28B
PE Ratio
-
EV/EBITDA
7.94
Price/Sales
0.54
Price/Book
0.69
PEG Ratio
0.17

Financials

Revenue
$18.79B
Gross Profit
$8.27B
EBITDA
$4.70B
EPS, ttm
-$3.83
Profit Margin
-
Revenue/Employee
$441.82K
Next Earnings Date
2/7/2020 (88 days)
Debt to Equity
197%
Debt
$28.88B
Cash
$1.80B
Net Debt
$27.08B

Performance

Beta
1.34
200 Day Moving Avg
$11.19
50 Day Moving Avg
$7.54
52 Week Change
-60.34%
YTD Change
-41.00%
1 Month Change
42.42%
3 Month Change
27.57%
6 Month Change
-36.30%
1 Year Change
-60.99%
2 Year Change
-21.39%
5 Year Change
-83.98%

Share Count

Shares Outstanding
1.1B
Float
1.1B
Restricted Shares
85.3K
Restricted Shares, %
0.01%

Teva Pharmaceutical Industries Ltd. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Generic

CEO: Kåre Schultz

Website: http://www.tevapharm.com

Description: Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Employees: 42,535